SCHEMBL9510122

SCHEMBL9510122

CC[C@H](C)CCCCCCOc1ncc(-c2ccc(OCCCCC[C@@H](C)CC)cc2)cn1

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
RARB P10826 4/20 0.44
CYP2D6 P10635 6/20 0.42
CYP3A4 P08684 5/20 0.42
CYP19A1 P11511 4/20 0.40
CYP2C9 P11712 4/20 0.40
CYP2C19 P33261 4/20 0.40
KDM4E B2RXH2 4/20 0.39
ALDH1A1 P00352 3/20 0.39
HPGD P15428 3/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
HTT P42858 1/20 0.39
NPC1 O15118 3/20 0.38
RAB9A P51151 3/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
HSD17B10 Q99714 1/20 0.38
MAPT P10636 1/20 0.38
CYP1A2 P05177 2/20 0.37
SLC2A1 P11166 1/20 0.37
NR5A1 Q13285 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9506293 0.96 RARB (0.46) RARBCYP2D6CYP3A4CYP19A1CYP2C9
SCHEMBL9506287 0.96 RARB (0.46) RARBCYP2D6CYP3A4CYP19A1CYP2C9
SCHEMBL9508441 0.96 RARB (0.46) RARBCYP2D6CYP3A4CYP19A1CYP2C9
SCHEMBL9508435 0.96 RARB (0.46) RARBCYP2D6CYP3A4CYP19A1CYP2C9
SCHEMBL9506169 0.88 NR5A1 (0.42) RARBCYP2D6CYP3A4CYP19A1CYP2C9
SCHEMBL9506180 0.88 NR5A1 (0.42) RARBCYP2D6CYP3A4CYP19A1CYP2C9
SCHEMBL20358289 0.87 RARB (0.54) RARBCYP2D6CYP3A4CYP19A1CYP2C9
SCHEMBL10427318 0.86 NPC1 (0.56) RARBCYP2D6CYP3A4CYP19A1CYP2C9
SCHEMBL9508448 0.85 RARB (0.52) RARBCYP2D6CYP3A4CYP19A1CYP2C9
SCHEMBL8879728 0.85

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0295370-B1 LIQUID-CRYSTALLINE 5-PHENYL PYRIMIDINE DERIVATIVES WITH AN SC OR SC (ASTERISK) PHASE, AND METHOD FOR PREPARING THEM HOECHST AKTIENGESELLSCHAFT (DE) 1993-08-11 EP disclosed
US-4906752-A Liquid-crystal 5-phenylpyrimidine derivatives having sc or sc* phases and a process for preparing them HOECHST AKTIENGESELLSCHAFT (DE) 1990-03-06 US disclosed
EP-0295370-A1 Liquid-crystalline 5-phenyl pyrimidine derivatives with an Sc or Sc (asterisk) phase, and method for preparing them HOECHST AKTIENGESELLSCHAFT (DE) 1988-12-21 EP disclosed